Richard Silver to Protein Kinase Inhibitors
This is a "connection" page, showing publications Richard Silver has written about Protein Kinase Inhibitors.
Connection Strength
0.170
-
Antifibrotic efficacy of nintedanib in a cellular model of systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol. 2019 Jul-Aug; 37 Suppl 119(4):115-124.
Score: 0.137
-
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities. Arthritis Rheumatol. 2019 02; 71(2):182-195.
Score: 0.033